One in eight men will be affected by prostate cancer (PCa) in their lives. While the current
clinical standard prognostic marker for PCa is the Gleason score, it is subject to inter-reviewer …

Background Diffusion‐weighted imaging (DWI) is commonly used to detect prostate cancer,
and a major clinical challenge is differentiating aggressive from indolent disease. Purpose …

Prostate cancer is the most commonly diagnosed cancer in men, accounting for 27% of the
new male cancer diagnoses in 2022. If organ-confined, removal of the prostate through …

Purpose Digital pathology is becoming an increasingly popular area of advancement in both
research and clinically. Pathologists are now able to manage and interpret slides digitally, …

Simple Summary Prostate cancer (PCa) is the leading non-cutaneous male cancer
diagnosis in the United States. This study used radiomic features calculated from T2-weighted …

Background Autopsy-based radio-pathomic maps of glioma pathology have shown substantial
promise inidentifying areas of non-enhancing tumor presence, which may be able to …

The latent space of a generative adversarial network (GAN) may model pathologically-significant
semantics with unsupervised learning. To explore this phenomenon, we trained and …

The presence and extent of cribriform patterned Gleason 4 (G4) glands are associated with
poor prognosis following radical prostatectomy. This study used whole-mount prostate …

Background This study identified a clinically significant subset of glioma patients with tumor
outside of contrast-enhancement present at autopsy, and subsequently developed a method …

Current MRI signatures of brain cancer often fail to identify regions of hypercellularity beyond
the contrast enhancing region. Therefore, this study used autopsy tissue samples aligned …